Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 35
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Physiol Res ; 71(3): 389-399, 2022 07 29.
Artículo en Inglés | MEDLINE | ID: mdl-35616040

RESUMEN

Therapeutic approaches to treat joint contracture after anterior cruciate ligament (ACL) reconstruction have not been established. Arthrofibrosis accompanied by joint inflammation following ACL reconstruction is a major cause of arthrogenic contracture. In this study, we examined whether anti-inflammatory treatment using low-level laser therapy (LLLT) can prevent ACL reconstruction-induced arthrogenic contracture. Rats underwent ACL transection and reconstruction surgery in their right knees. Unoperated left knees were used as controls. After surgery, rats were reared with or without daily LLLT (wavelength: 830 nm; power output: 150 mW; power density: 5 W/cm2; for 120 s/day). We assessed the passive extension range of motion (ROM) after myotomy at one and two weeks post-surgery; the reduction in ROM represents the severity of arthrogenic contracture. ROM was markedly decreased by ACL reconstruction at both time points; however, LLLT partially attenuated the decrease in ROM. One week after ACL reconstruction, the gene expression of the proinflammatory cytokine interleukin-1beta in the joint capsule was significantly upregulated, and this upregulation was significantly attenuated by LLLT. Fibrotic changes in the joint capsule, including upregulation of collagen type I and III genes, shortening of the synovium, and thickening were caused by ACL reconstruction and seen at both time points. LLLT attenuated these fibrotic changes as well. Our results indicate that LLLT after ACL reconstruction could attenuate the formation of arthrogenic contracture through inhibition of inflammation and fibrosis in the joint capsule. Thus, LLLT may become a novel therapeutic approach for ACL reconstruction-induced joint contracture.


Asunto(s)
Lesiones del Ligamento Cruzado Anterior , Reconstrucción del Ligamento Cruzado Anterior , Contractura , Terapia por Luz de Baja Intensidad , Animales , Lesiones del Ligamento Cruzado Anterior/complicaciones , Lesiones del Ligamento Cruzado Anterior/cirugía , Reconstrucción del Ligamento Cruzado Anterior/efectos adversos , Contractura/etiología , Contractura/prevención & control , Fibrosis , Inflamación/patología , Articulación de la Rodilla/cirugía , Terapia por Luz de Baja Intensidad/efectos adversos , Rango del Movimiento Articular , Ratas
2.
J Cosmet Dermatol ; 21(10): 4623-4630, 2022 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-35152532

RESUMEN

BACKGROUND: The present study aimed to explore the formation mechanism of the bilayer capsular contracture after augmentation mammoplasty with a rough-surface prosthesis and its prevention and treatment. METHODS: The nursing process, clinical signs, intraoperative findings, and pathological data after an augmentation mammoplasty with rough-surface prosthesis were observed and collected, the formation mechanism of the bilayer capsular contracture was analyzed, and the prevention and treatment were also discussed. RESULTS: A total of 18 patients were included into the present study, among which 15 patients underwent capsule relaxation plus secondary augmentation mammoplasty and three patients encountered a single-layer capsular contracture after the operation; the recurrence rate was 16%. All patients were followed up for 1-13 years without a presentation of recurrence. CONCLUSIONS: The formation of the bilayer capsular contracture after augmentation mammoplasty is correlated with the formation of the inner capsule, inadequate separation of cavities, foreign body reaction, and an improper massage of the breasts, and the effective preventive measures include removing new cavities, resecting the capsular contracture capsule, stopping bleeding, replanting a rough-surface or smooth prosthesis, and correcting breast massaging.


Asunto(s)
Contractura , Mamoplastia , Humanos , Mamoplastia/efectos adversos , Mama/patología , Mama/cirugía , Prótesis e Implantes , Reacción a Cuerpo Extraño , Contractura/etiología , Contractura/prevención & control , Contractura/patología
3.
BMJ Open ; 11(7): e044674, 2021 07 06.
Artículo en Inglés | MEDLINE | ID: mdl-34230015

RESUMEN

INTRODUCTION: Contractures are frequent causes of reduced mobility in children with cerebral palsy (CP) already at the age of 2-3 years. Reduced muscle use and muscle growth have been suggested as key factors in the development of contractures, suggesting that effective early prevention may have to involve stimuli that can facilitate muscle growth before the age of 1 year. The present study protocol was developed to assess the effectiveness of an early multicomponent intervention, CONTRACT, involving family-oriented and supervised home-based training, diet and electrical muscle stimulation directed at facilitating muscle growth and thus reduce the risk of contractures in children at high risk of CP compared with standard care. METHODS AND ANALYSIS: A two-group, parallel, open-label randomised clinical trial with blinded assessment (n=50) will be conducted. Infants diagnosed with CP or designated at high risk of CP based on abnormal neuroimaging or absent fidgety movement determined as part of General Movement Assessment, age 9-17 weeks corrected age (CA) will be recruited. A balanced 1:1 randomisation will be made by a computer. The intervention will last for 6 months aiming to support parents in providing daily individualised, goal-directed activities and primarily in lower legs that may stimulate their child to move more and increase muscle growth. Guidance and education of the parents regarding the nutritional benefits of docosahexaenic acid (DHA) and vitamin D for the developing brain and muscle growth will be provided. Infants will receive DHA drops as nutritional supplements and neuromuscular stimulation to facilitate muscle growth. The control group will receive standard care as offered by their local hospital or community. Outcome measures will be taken at 9, 12, 18, 24, 36 and 48 months CA. Primary and secondary outcome measure will be lower leg muscle volume and stiffness of the triceps surae musculotendinous unit together with infant motor profile, respectively. ETHICS AND DISSEMINATION: Full approval from the local ethics committee, Danish Committee System on Health Research Ethics, Region H (H-19041562). Experimental procedures conform with the Declaration of Helsinki. TRIAL REGISTRATION NUMBER: NCT04250454. EXPECTED RECRUITMENT PERIOD: 1 January 2021-1 January 2025.


Asunto(s)
Parálisis Cerebral , Contractura , Parálisis Cerebral/prevención & control , Preescolar , Contractura/prevención & control , Intervención Educativa Precoz , Humanos , Lactante , Padres , Modalidades de Fisioterapia , Ensayos Clínicos Controlados Aleatorios como Asunto
4.
Clin Rehabil ; 33(12): 1919-1930, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31423822

RESUMEN

OBJECTIVE: To establish feasibility of initiating electrical stimulation treatment of wrist extensors and flexors in patients early after stroke to prevent muscle contractures and pain. DESIGN: Feasibility randomized controlled trial with economic evaluation. SETTING: A specialist stroke unit in Nottinghamshire. SUBJECTS: A total of 40 patients recruited within 72 hours post-stroke with arm hemiparesis. INTERVENTIONS: Participants were randomized to receive usual care or usual care and electrical stimulation to wrist flexors and extensors for 30 minutes, twice a day, five days a week for three months. Initial treatment was delivered by an occupational therapist or physiotherapist who trained participants to self-manage subsequent treatments. MEASURES: Measures of feasibility included recruitment and attrition rates, completion of treatment, and successful data collection. Outcome data on wrist range of motion, pain, arm function, independence, quality of life, and resource use were measured at 3-, 6-, and 12-months post-randomization. RESULTS: A total of 40 participants (of 215 potentially eligible) were recruited in 15 months (20 men; mean age: 72 (SD: 13.0)). Half the participants lacked mental capacity and were recruited by consultee consent. Attrition at three-month follow-up was 12.5% (death (n = 2), end-of-life care (n = 2), and unable to contact (n = 1)). Compliance varied (mean: 65 (SD: 53)) and ranged from 10 to 166 treatments per patient (target dosage was 120). Data for a valid economic analysis can be adequately collected. CONCLUSION: Early initiation of electrical stimulation was acceptable and feasible. Data collection methods used were feasible and acceptable to participants. A large definitive study is needed to determine if electrical stimulation is efficacious and cost effective.


Asunto(s)
Contractura/prevención & control , Terapia por Estimulación Eléctrica , Dolor/prevención & control , Paresia/rehabilitación , Accidente Cerebrovascular/complicaciones , Muñeca , Adulto , Anciano , Anciano de 80 o más Años , Contractura/etiología , Estudios de Factibilidad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Dolor/etiología , Paresia/etiología , Calidad de Vida , Rango del Movimiento Articular , Rehabilitación de Accidente Cerebrovascular
5.
Lasers Surg Med ; 51(10): 910-919, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-31278757

RESUMEN

BACKGROUND AND OBJECTIVES: Wound contracture formation from excessive myofibroblast activity can result in debilitating morbidities. There are currently no treatments to prevent contracture. Photochemical tissue passivation (PTP), an established, safe, and user-friendly treatment modality, crosslinks collagen by a light-activated process, thus modulating the wound healing response and scarring. We hypothesised that PTP treatment would reinforce wounds by blunting the fibrotic response thus limiting contracture. STUDY DESIGN/MATERIALS AND METHODS: Full-thickness, 1 cm × 1 cm excisional wounds were created on the dorsum of 32 C57BL/6 mice. Treated wounds were painted with photosensitizing dye and exposed to visible light. Wounds were serially photographed over 6 weeks to measure wound contracture. At 7, 14, 21, and 42 days after wound creation, mice were euthanized and wounds were harvested for histologic review by a dermatopathologist. RESULTS: By Day 7, control wounds had significantly more contracture than those treated with PTP (33.0 ± 17.1% and 19.3 ± 9.0%, respectively; P = 0.011). PTP-treated wounds maintained approximately 20% less contracture than controls from Day 14 and on (P < 0.05). By Day 42, wounds had contracted by 86.9 ± 5.5% in controls and 64.2 ± 3.2% in PTP-treated wounds (P < 0.03). Histologically, PTP wounds had earlier growth and development of dermal collagen, neovascularization, and development of skin appendages, compared with control wounds. CONCLUSIONS: PTP significantly limits contracture of full-thickness wounds and improves wound healing. PTP-treated wounds histologically demonstrate more mature structural organization than untreated wounds and closely resemble native skin. PTP treatment may be applicable not only for excisional wounds, but also for wounds with a high incidence of contracture and associated morbidity. Lasers Surg. Med. © 2019 Wiley Periodicals, Inc.


Asunto(s)
Cicatriz/prevención & control , Contractura/prevención & control , Fotoquimioterapia/métodos , Fármacos Fotosensibilizantes/uso terapéutico , Rosa Bengala/uso terapéutico , Cicatrización de Heridas/efectos de los fármacos , Animales , Cicatriz/etiología , Contractura/etiología , Ratones , Ratones Endogámicos C57BL , Fármacos Fotosensibilizantes/farmacología , Rosa Bengala/farmacología , Resultado del Tratamiento , Cicatrización de Heridas/fisiología
6.
J Physiother ; 65(2): 88-94, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-30910563

RESUMEN

QUESTION: In adults undergoing rehabilitation after stroke, does 1 hour of additional active repetitive reaching per day prevent or reduce upper limb contracture? DESIGN: Multi-centre, randomised controlled trial with concealed allocation, assessor blinding, and intention-to-treat analysis. PARTICIPANTS: Fifty adults undergoing rehabilitation after stroke who were unable to actively extend the affected wrist past neutral or were unable to flex the affected shoulder to 90 deg. SETTING: Three inpatient rehabilitation units in Australia. INTERVENTION: Both groups received usual upper limb therapy 5 days a week for 5 weeks. In addition, the experimental group received up to 1 hour a day of active, intensive, repetitive upper limb training using the SMART Arm device 5 days a week for 5 weeks. OUTCOME MEASURES: Measures were collected at baseline (Week 0), after intervention (Week 5) and at follow-up (Week 7). The primary outcomes were passive range of wrist extension, elbow extension, and shoulder flexion at Week 5. The secondary outcomes were: the three primary outcomes measured at Week 7; passive range of shoulder external rotation; arm function; and pain at rest, on movement and during sleep measured at Weeks 5 and 7. RESULTS: Following an average of 2310 reaching repetitions, the mean effect at Week 5 on passive range of wrist extension was 1 deg (95% CI -6 to 8), elbow extension -6 deg (95% CI -12 to -1), and shoulder flexion 5 deg (95% CI -8 to 17). There were no statistically significant or clinically important effects of the intervention on any secondary outcomes. CONCLUSION: In adults who are already receiving task-specific motor training for upper limb rehabilitation following stroke, 5 weeks of up to 1 hour of additional daily active repetitive motor training using the SMART Arm device did not prevent or reduce contracture in upper limb muscles. TRIAL REGISTRATION: ACTRN12614001162606.


Asunto(s)
Contractura/prevención & control , Rehabilitación de Accidente Cerebrovascular , Extremidad Superior/fisiopatología , Anciano , Anciano de 80 o más Años , Australia , Contractura/fisiopatología , Terapia por Estimulación Eléctrica , Femenino , Humanos , Masculino , Persona de Mediana Edad , Dimensión del Dolor , Rango del Movimiento Articular , Método Simple Ciego
7.
J Urol ; 202(3): 617-622, 2019 09.
Artículo en Inglés | MEDLINE | ID: mdl-30747872

RESUMEN

PURPOSE: Increased complications following failed hypospadias repairs suggest that impaired wound healing is a contributing factor. We used perioperative hyperbaric oxygen therapy to promote wound healing determined by graft take in staged tubularized autograft reoperations using oral graft. MATERIALS AND METHODS: Hyperbaric oxygen therapy was recommended for patients with 3 or more failed hypospadias repairs, comprising 20 preoperative and 10 postoperative sessions. All patients underwent reoperative staged tubularized autograft repair using oral mucosa. Graft lengths and widths were measured at grafting and again at the second stage, from which graft area was calculated. The primary outcomes were percent graft contracture and graft failure, defined as contracture 50% or greater. Patients who received hyperbaric oxygen therapy were compared to other patients who underwent reoperative staged tubularized autograft who did not receive therapy. RESULTS: Among 57 patients 32 received hyperbaric oxygen therapy and 25 did not as they had fewer than 3 prior repairs, or were not able to receive treatment due to insurance issues or lack of local availability. Grafts were healthier in those receiving hyperbaric oxygen therapy, with significantly less percent area contracture (9% vs 26%, p=0.04) and graft failure (6% vs 28%, p=0.03) compared to those not receiving therapy, although treated patients had significantly more prior failed hypospadias repairs. CONCLUSIONS: Hyperbaric oxygen therapy improved graft take in hypospadias reoperations. This observation also calls attention to wound healing as another variable to consider in hypospadias surgery.


Asunto(s)
Contractura/prevención & control , Oxigenoterapia Hiperbárica , Hipospadias/cirugía , Mucosa Bucal/trasplante , Autoinjertos , Contractura/fisiopatología , Supervivencia de Injerto/fisiología , Humanos , Masculino , Reoperación , Trasplante Autólogo/métodos , Cicatrización de Heridas/fisiología
8.
Inflammation ; 42(3): 857-873, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-30506108

RESUMEN

We investigated whether the combination of exercise and anti-inflammatory/anti-fibrotic treatment using low-level laser therapy (LLLT) promotes recovery from joint contracture without arthrogenic contracture progression. Rat knees were immobilized for 3 weeks in a flexed position. After fixator removal, rats were divided into no intervention (RM), daily treadmill walking (WALK), and daily treadmill walking and LLLT (W + L) groups. Total and arthrogenic contractures were assessed by restrictions of passive range of motion (ROM) before (m-ROM) and after myotomy (a-ROM), respectively. After 7 days of remobilization, m-ROM restriction decreased equally in all groups. Conversely, a-ROM restriction further increased after remobilization in the RM and WALK groups. Furthermore, this restriction was significantly larger in the WALK group compared with the RM group. In the W + L group, however, progression of a-ROM restriction during remobilization was prevented. After 1 or 7 days of remobilization, inflammatory and fibrotic reactions in the joint capsule were induced in the RM group and were more pronounced in the WALK group, but these reactions were milder in the W + L group than in the WALK group. m-ROM restriction representing total contracture initially established by immobilization was partially improved by remobilization. Additional LLLT and exercise intervention did not further reduce total contracture, but LLLT suppressed the progression of arthrogenic contracture caused by ambulation and treadmill exercise. Therefore, exercise with LLLT in the early phase of remobilization would be one possible adjunct therapy to prevent further progression of arthrogenic contracture.


Asunto(s)
Contractura/prevención & control , Progresión de la Enfermedad , Fibrosis/prevención & control , Inflamación/prevención & control , Articulación de la Rodilla/fisiopatología , Terapia por Luz de Baja Intensidad , Condicionamiento Físico Animal , Animales , Contractura/terapia , Articulación de la Rodilla/patología , Fuerza Muscular , Miotomía , Rango del Movimiento Articular , Ratas
9.
BMJ Open ; 6(1): e010079, 2016 Jan 04.
Artículo en Inglés | MEDLINE | ID: mdl-26729394

RESUMEN

INTRODUCTION: Approximately 70% of patients with stroke experience impaired arm function, which is persistent and disabling for an estimated 40%. Loss of function reduces independence in daily activities and impacts on quality of life. Muscles in those who do not recover functional movement in the stroke affected arm are at risk of atrophy and contractures, which can be established as early as 6 weeks following stroke. Pain is also common. This study aims to evaluate the feasibility of a randomised controlled trial to test the efficacy and cost-effectiveness of delivering early intensive electrical stimulation (ES) to prevent post-stroke complications in the paretic upper limb. METHODS AND ANALYSIS: This is a feasibility randomised controlled trial (n=40) with embedded qualitative studies (patient/carer interviews and therapist focus groups) and feasibility economic evaluation. Patients will be recruited from the Stroke Unit at the Nottingham University Hospitals National Health Service (NHS) Trust within 72 h after stroke. Participants will be randomised to receive usual care or usual care and early ES to the wrist flexors and extensors for 30 min twice a day, 5 days a week for 3 months. The initial treatment(s) will be delivered by an occupational therapist or physiotherapist who will then train the patient and/or their nominated carer to self-manage subsequent treatments. ETHICS AND DISSEMINATION: This study has been granted ethical approval by the National Research Ethics Service, East Midlands Nottingham1 Research Ethics Committee (ref: 15/EM/0006). To our knowledge, this is the first study of its kind of the early application (within 72 h post-stroke) of ES to both the wrist extensors and wrist flexors of stroke survivors with upper limb impairment. The results will inform the design of a definitive randomised controlled trial. Dissemination will include 2 peer-reviewed journal publications and presentations at national conferences. TRIAL REGISTRATION NUMBER: ISRCTN1648908; Pre-results. Clinicaltrials.gov ID: NCT02324634.


Asunto(s)
Contractura/prevención & control , Terapia por Estimulación Eléctrica/métodos , Dolor Musculoesquelético/prevención & control , Paresia/complicaciones , Accidente Cerebrovascular/complicaciones , Adolescente , Adulto , Anciano , Brazo , Protocolos Clínicos , Contractura/etiología , Estudios de Factibilidad , Humanos , Persona de Mediana Edad , Músculo Esquelético/fisiología , Dolor Musculoesquelético/etiología , Cooperación del Paciente , Calidad de Vida , Resultado del Tratamiento , Muñeca , Adulto Joven
10.
Int Wound J ; 13(1): 65-71, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24602064

RESUMEN

This study confirms that botulinum neurotoxin type A (BoNT-A) decreases capsular contracture and elucidates a possible mechanism. Silicone blocks were implanted subcutaneously in 20 mice. The experimental groups received BoNT-A (1, 2·5 or 5 U) instilled into the subcutaneous pocket. After 30 days, periprosthetic capsules were harvested and evaluated. The effect of BoNT-A on the differentiation of human dermal fibroblasts to myofibroblasts in culture was examined by Western blot analysis. Changes in transforming growth factor-beta1 (TGF-ß1) expression in cultured fibroblasts were determined by enzyme-linked immunosorbent assay (ELISA). In in vivo study, the thickness of capsules (P < 0·05) and the number of alpha-smooth muscle actin (α-SMA)(+) cells in capsules (P < 0·05) were significantly decreased in the experimental groups. TGF-ß1 was significantly underexpressed in the experimental groups (P < 0·05). In in vitro study, BoNT-A did not significantly affect fibroblast viability. Western blot analysis showed that α-SMA protein levels were significantly decreased in the experimental groups (P < 0·05). Based on ELISA, the amount of TGF-ß1 was significantly decreased in the experimental groups (P < 0·05), especially cells treated with a high dose of BoNT-A (P < 0·001). This study confirms that BoNT-A prevents capsular formation around silicone implants, possibly by blocking TGF-ß1 signalling and interrupting the differentiation of fibroblasts to myofibroblasts.


Asunto(s)
Toxinas Botulínicas Tipo A/administración & dosificación , Implantes de Mama , Contractura/prevención & control , Neurotoxinas/administración & dosificación , Geles de Silicona , Actinas/metabolismo , Animales , Western Blotting , Diferenciación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Ensayo de Inmunoadsorción Enzimática , Femenino , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Ratones , Modelos Animales , Miofibroblastos/efectos de los fármacos , Factor de Crecimiento Transformador beta1/metabolismo
11.
Rehabilitación (Madr., Ed. impr.) ; 49(1): 45-48, ene.-mar. 2015. tab
Artículo en Español | IBECS | ID: ibc-132955

RESUMEN

La fascitis eosinofílica es un síndrome esclerodermiforme poco frecuente y de etiología desconocida que afecta predominantemente a las extremidades. Se han barajado varias hipótesis sobre su etiología y en algunos casos se ha descrito antecedente traumático. Presentamos un caso de una paciente de 54 años que tras presentar traumatismo sobre las rodillas inicia un cuadro de mialgias, induración cutánea y retracción progresiva de diversas articulaciones iniciado en los miembros inferiores y posteriormente en los miembros superiores y en el tronco. Realizamos el seguimiento de la paciente, mostrando su manejo desde el punto de vista rehabilitador y evolución. La paciente mejoró tanto sus balances articulares como la marcha y el dolor. La fascitis eosinofílica es una enfermedad infrecuente en la que debemos realizar el diagnóstico diferencial con otros síndromes esclerodermiformes. La rehabilitación puede ayudar a reducir y evitar el progreso de las contracturas (AU)


Eosinophilic fasciitis is a rare scleroderma syndrome of unknown cause that predominantly affects the extremities. Several hypotheses have been proposed to explain its etiology and there have been reports of some patients with a history of trauma. We present the case of a 54-year-old woman who, after a knee injury, developed myalgia, progressive skin induration and retraction of various joints, starting in the lower limbs and spreading to the upper limbs and trunk. We describe the rehabilitation management and outcome of this patient. The patient showed improvement in both balance, joint pain, and gait. Eosinophilic fasciitis is a rare disease that requires a differential diagnosis with other scleroderma syndromes. Rehabilitation can help reduce and prevent progression of contractures (AU)


Asunto(s)
Humanos , Femenino , Persona de Mediana Edad , Fascitis/diagnóstico , Fascitis/rehabilitación , Marcha/fisiología , Artropatías/rehabilitación , Diagnóstico Diferencial , Contractura/prevención & control , Contractura/rehabilitación , Terapia por Estimulación Eléctrica/métodos , Corticoesteroides/uso terapéutico , Cimetidina/uso terapéutico , Mialgia/complicaciones , Terapia por Estimulación Eléctrica/instrumentación , Fascitis/terapia , Terapia por Estimulación Eléctrica , Mialgia/rehabilitación , Terapia por Estimulación Eléctrica/tendencias
12.
Acta cir. bras ; 24(1): 7-12, Jan.-Feb. 2009. ilus, tab
Artículo en Inglés | LILACS | ID: lil-503098

RESUMEN

PURPOSE: To evaluate the effect of low intensity laser on the pseudocapsula contraction that occurs around silicone implants. METHODS: 60 male rats divided in two experimental groups received a silicone implant in the subcutaneous of the dorsal region. Group I: animals received implants in the subcutaneous dorsal region and did not receive any treatment; Group II: animals received seven irradiation sessions with low intensity laser after they had received subcutaneous implants. Thirty, 60 and 180 days after the surgery, tonometric evaluation of the implants was conducted. After that, the animals were sacrificed, study material was removed and prepared for histological examination. The thickness of the pseudocapsule and the inflammatory reaction were morphometrically quantified. Data obtained were statistically analyzed using the Variance method, and Tukey's Test(P<0.0 5). RESULTS: Group II animals had significant lower pressure. The histological study did not show a significant difference between the groups, but only a higher number of swollen vessels in Group II. The thickness of pseudocapsule around Group II's implants lower than in Group I. CONCLUSION: The low intensity laser modify tissue's reparation process around the implants suggesting it may be useful to model contractures that are formed around silicone implants.


OBJETIVO: Avaliar o efeito do laser de baixa intensidade sobre a contração da pseudocápsula que ocorre ao redor de implantes de silicone. MÉTODOS: 60 ratos machos divididos em dois grupos receberam implante de silicone. Grupo I: implante no subcutâneo da região dorsal, sem tratamento após a cirurgia; Grupo II: animais receberam sete sessões de irradiação com laser de baixa intensidade após o implante. Trinta, 60 e 180 dias após a cirurgia, foi feita a tonometria dos implantes, Em seguida, os animais foram sacrificados, removendo-se o material de estudo que foi preparado para exame histológico, avaliando-se morfometricamente a espessura da pseudocápsula e a reação inflamatória. A análise estatistica pela técnica da Análise de Variância e Teste de Tukey (P<0.0 5). RESULTADOS: Pressões significativamente menores foram encontradas nos animais do grupo Grupo II. O estudo histológico não mostrou diferença significativa entre os grupos, destacando-se apenas maior quantidade de vasos intumescidos no Grupo II. A espessura da pseudocápsula foi menor no Grupo II. CONCLUSÃO: O laser de baixa intensidade altera o processo de reparação tecidual ao redor dos implantes, sugerindo que o mesmo possa ser útil para a modelação das contraturas que se estabelecem ao redor dos implantes de silicone.


Asunto(s)
Animales , Masculino , Ratas , Implantes de Mama , Implantes Experimentales , Terapia por Luz de Baja Intensidad , Siliconas , Análisis de Varianza , Contractura/patología , Contractura/prevención & control , Contractura/radioterapia , Modelos Animales de Enfermedad , Modelos Animales , Distribución Aleatoria , Ratas Wistar
13.
Acta Cir Bras ; 24(1): 7-12, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19169535

RESUMEN

PURPOSE: To evaluate the effect of low intensity laser on the pseudocapsule contraction that occurs around silicone implants. METHODS: 60 male rats divided in two experimental groups received a silicone implant in the subcutaneous of the dorsal region. Group I: animals received implants in the subcutaneous dorsal region and did not receive any treatment; Group II: animals received seven irradiation sessions with low intensity laser after they had received subcutaneous implants. Thirty, 60 and 180 days after the surgery, tonometric evaluation of the implants was conducted. After that, the animals were sacrificed, study material was removed and prepared for histological examination. The thickness of the pseudocapsule and the inflammatory reaction were morphometrically quantified. Data obtained were statistically analyzed using the Variance method, and Tukey's Test(P<0.0 5). RESULTS: Group II animals had significant lower pressure. The histological study did not show a significant difference between the groups, but only a higher number of swollen vessels in Group II. The thickness of pseudocapsule around Group II's implants lower than in Group I. CONCLUSION: The low intensity laser modify tissue's reparation process around the implants suggesting it may be useful to model contractures that are formed around silicone implants.


Asunto(s)
Implantes de Mama , Implantes Experimentales , Terapia por Luz de Baja Intensidad , Siliconas , Análisis de Varianza , Animales , Contractura/patología , Contractura/prevención & control , Contractura/radioterapia , Modelos Animales de Enfermedad , Masculino , Modelos Animales , Distribución Aleatoria , Ratas , Ratas Wistar
14.
J Craniofac Surg ; 19(4): 989-1006, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18650721

RESUMEN

Hypertrophic scars and keloids are challenging to manage, particularly as sequelae of burns in children in whom the psychologic burden and skin characteristics differ substantially from adults. Prevention of hypertrophic scars and keloids after burns is currently the best strategy in their management to avoid permanent functional and aesthetical alterations. Several actions can be taken to prevent their occurrence, including parental and children education regarding handling sources of fire and flammable materials, among others. Combination of therapies is the mainstay of current burn scar management, including surgical reconstruction, pressure therapy, silicon gels and sheets, and temporary garments. Other adjuvant therapies such as topical imiquimod, tacrolimus, and retinoids, as well as intralesional corticosteroids, 5-fluorouracil, interferons, and bleomycin, have been used with relative success. Cryosurgery and lasers have also been reported as alternatives. Newer treatments aimed at molecular targets such as cytokines, growth factors, and gene therapy, currently in developing stages, are considered the future of the treatment of postburn hypertrophic scars and keloids in children.


Asunto(s)
Quemaduras/complicaciones , Cicatriz Hipertrófica/prevención & control , Contractura/prevención & control , Queloide/prevención & control , Adolescente , Quemaduras/rehabilitación , Quemaduras/terapia , Niño , Preescolar , Cicatriz Hipertrófica/etiología , Cicatriz Hipertrófica/terapia , Contractura/etiología , Contractura/terapia , Procedimientos Quirúrgicos Dermatologicos , Humanos , Lactante , Queloide/etiología , Queloide/terapia , Piel/lesiones , Piel/fisiopatología , Cicatrización de Heridas/fisiología
15.
Aesthetic Plast Surg ; 29(3): 174-80, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-15948022

RESUMEN

Although commonly used biomaterials are physically and chemically stable, nonimmunogenic, and nontoxic, implanted and blood-contact biomaterials trigger a wide variety of unwanted responses, including inflammation, thrombosis, infection, and fibrosis. Peri-implant fibrosis is the response most commonly seen by plastic surgeons. In this study, the authors hypothesized that as hyaluronic acid (HA) reduces scar formation by inhibiting the activity of mononuclear phagocytes and lymphocytes, human amniotic fluid (HAF), which contains high concentrations of HA, HA-stimulating activator (HASA), and other factors, might prevent the formation of fibrous capsules and capsule contracture when applied intraluminally. Two 1 x 1-cm silicone blocks were placed dorsally into separate surgically created pockets underneath the panniculus carnosus muscle, distant from the incisions, in each of the 10 rats in the study. At the time of implant insertion, 2 ml of HAF was instilled into the cranially located pockets in group 1, whereas 2 ml of saline solution was instilled into the caudally located pockets in group 2. After 6 months, intracapsular static and dynamic pressure measurements were made, and then all the peri-implant capsules were excised and fixed in 10% neutral buffered formaldehyde. The thicknesses of the capsules were measured in three different areas of each section, and a mean was calculated. Capsular firmness, according to the static and dynamic pressure readings, was significantly greater in the control group, which had saline solution introduced into the pocket, than in the treatment group, which had HAF used in the same manner. The mean total thickness of the capsules surrounding the implants was 876.7 microm in the control group, as comparied with 466.8 microm in the HAF-treated group. This difference was statistically significant (p < 0.001). Because of its ability to reduce capsular thickness and firmness and also because it can be stored in a freezer if it is prepared in a cell-free manner, HAF would appear to be a useful adjunct in the prevention of capsular contracture formation.


Asunto(s)
Adyuvantes Inmunológicos/administración & dosificación , Líquido Amniótico , Implantación de Mama , Contractura/prevención & control , Ácido Hialurónico/administración & dosificación , Líquido Amniótico/química , Animales , Mama/patología , Implantación de Mama/efectos adversos , Implantación de Mama/métodos , Ratas , Ratas Sprague-Dawley
16.
Zhonghua Nan Ke Xue ; 10(4): 287-9, 2004 Apr.
Artículo en Chino | MEDLINE | ID: mdl-15148927

RESUMEN

OBJECTIVE: To analyse different factors related to the occurrence of bladder neck contracture (BNC) and to find possible ways of reducing this complication. METHODS: All putative factors and the numbers of BNC cases were studied with statistical analyses in 1,017 cases that had undergone transurethral resection of the prostate (TURP). RESULTS: The morbidity of BNC after TURP was significantly higher than that of open operations. Small size of the prostate, longer time of operation, higher power in resection and prostatitis were factors of BNC. CONCLUSION: Properties of the prostate and electrical current injuries of resection are the primary factors of BNC. The selection of patients and techniques of TURP are most important in decreasing the morbidity of BNC.


Asunto(s)
Contractura/etiología , Complicaciones Posoperatorias/etiología , Resección Transuretral de la Próstata/efectos adversos , Vejiga Urinaria , Anciano , Anciano de 80 o más Años , Contractura/prevención & control , Humanos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/prevención & control
17.
Am J Surg ; 180(1): 55-7, 2000 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-11036142

RESUMEN

A variety of techniques have recently been advanced for delayed primary closure of wounds following emergent fasciotomy for compartment syndrome. We introduce a very simple, effective method for gradual reapproximation of margins using daily reapplication of Steri-strips (3M Surgical Products, St. Paul, Minnesota). This method allows final closure of fasciotomy wounds with simple suture in 5-8 days without scar contractures, marginal necrosis, infection, or significant pain. Moreover, because it requires no specialized equipment and can be applied in skilled nursing centers or at home by trained nurses, this technique could reduce the cost of caring for fasciotomy patients.


Asunto(s)
Vendajes , Síndromes Compartimentales/cirugía , Fasciotomía , Anciano , Antiinfecciosos Locales/uso terapéutico , Vendajes/economía , Cicatriz/prevención & control , Contractura/prevención & control , Costos de la Atención en Salud , Humanos , Persona de Mediana Edad , Necrosis , Dolor/prevención & control , Extractos Vegetales/uso terapéutico , Styrax , Infección de la Herida Quirúrgica/prevención & control , Técnicas de Sutura
18.
Otolaryngol Head Neck Surg ; 117(3 Pt 1): 276-9, 1997 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-9334777

RESUMEN

We present our experience in treating postlaryngectomy patients with respiratory disturbance caused by stricture of the permanent stoma by CO2 laser surgery. Laser surgery is a simple procedure that can be performed with the patient under local anesthesia without bleeding and with minimal damage to the adjacent strictures resulting in a minimal postoperative edema and contracture. In our opinion the CO2 laser is a useful surgical tool for enlargement of the airway lumen and for improvement of respiratory disturbance in postlaryngectomy patients with stomal stricture, and this procedure should be considered for treatment of selected patients.


Asunto(s)
Obstrucción de las Vías Aéreas/cirugía , Terapia por Láser , Estenosis Traqueal/cirugía , Traqueostomía , Anciano , Obstrucción de las Vías Aéreas/etiología , Anestesia Local , Anestésicos Locales/administración & dosificación , Dióxido de Carbono , Carcinoma/cirugía , Cicatriz/etiología , Cicatriz/cirugía , Contractura/prevención & control , Edema/prevención & control , Fibrosis , Estudios de Seguimiento , Hemorragia/prevención & control , Humanos , Neoplasias Laríngeas/cirugía , Laringectomía , Terapia por Láser/métodos , Lidocaína/administración & dosificación , Masculino , Persona de Mediana Edad , Estenosis Traqueal/etiología , Traqueostomía/efectos adversos , Cicatrización de Heridas
19.
Am J Physiol ; 271(6 Pt 2): H2515-9, 1996 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-8997312

RESUMEN

Protection of the ischemic myocardium by pretreatment with a high dose of 2,3-butanedione monoxime (BDM) is attributed to the enhancement of glycolytic ATP production rather than to the inhibition of contracture during mild ischemia. Our objective was to investigate whether the inhibition of contracture would protect the arrested heart during prolonged ischemia. Isolated perfused rat hearts were subjected to 30 min of low-flow ischemia followed by reperfusion. Ischemic hearts were treated with BDM (5 mmol/l) after beating stopped. BDM ameliorated the increase in intraventricular pressure after ischemia without significant changes in ATP levels and with a decreased accumulation of lactate. BDM treatment accelerated the recovery of function and high-energy phosphates with reduced myocardial Ca2+ overload. The results of this study suggested that inhibition of contracture can protect the heart from ischemia-reperfusion injury.


Asunto(s)
Contractura/prevención & control , Corazón , Isquemia Miocárdica/fisiopatología , Adenosina Trifosfato/metabolismo , Animales , Calcio/metabolismo , Diacetil/análogos & derivados , Diacetil/farmacología , Metabolismo Energético , Corazón/efectos de los fármacos , Técnicas In Vitro , Ácido Láctico/metabolismo , Masculino , Miocardio/metabolismo , Fosfocreatina/metabolismo , Ratas , Ratas Sprague-Dawley , Función Ventricular Izquierda
20.
Arch Phys Med Rehabil ; 73(2): 195-200, 1992 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-1543418

RESUMEN

The spinal cord injured patient has been the focus of clinical and research efforts to restore functional movement and to obtain therapeutic benefits by electric stimulation of upper motor neuron paralyzed muscles. This review article treats developments in this field from 1983 to 1990. Efforts have been directed to restoring ventilatory and bladder function, and to preventing secondary complications. Electric stimulation for improving ventilatory function has had reasonable success, and systems are commercially available. Electric stimulation for improving bladder function remains in the research stage in the US, although it has had some clinical success reported in Europe. Electric stimulation techniques to prevent or treat secondary complications have been applied to pressure ulcers, deep-venous thrombosis, contractures, spasticity, deconditioning due to lack of exercise, and muscle atrophy. Therapeutic electric stimulation techniques are largely research techniques. Much additional work remains to be done to solve the difficult problems associated with applying this technology in the treatment of patients with spinal cord injury.


Asunto(s)
Terapia por Estimulación Eléctrica/métodos , Traumatismos de la Médula Espinal/terapia , Contractura/prevención & control , Humanos , Espasticidad Muscular/prevención & control , Úlcera por Presión/prevención & control , Respiración , Traumatismos de la Médula Espinal/complicaciones , Traumatismos de la Médula Espinal/rehabilitación , Trombosis/prevención & control , Micción
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA